Fatal outcome of autosomal recessive polycystic kidney disease in neonates with recessive PKHD1 mutations

Medicine (Baltimore). 2020 May;99(19):e20113. doi: 10.1097/MD.0000000000020113.

Abstract

Autosomal recessive polycystic kidney disease (ARPKD) is the most common inherited childhood-onset renal disease, with underlying ciliopathy, and varies widely in clinical severity. The aim of this study was to describe the most severe form of ARPKD, with a fatal clinical course, and its association with mutations in polycystic kidney and hepatic disease 1 (fibrocystin) (PKHD1). Clinical, imaging, pathological, and molecular genetic findings were reviewed in patients prenatally affected with ARPKD and their families.Five unrelated Korean families, including 9 patients, were analyzed. Among the 9 patients, 2 fetuses died in utero, 6 patients did not survive longer than a few days, and 1 patient survived for 5 months with ventilator support and renal replacement therapy. A total of 6 truncating mutations (all nonsense) and 4 missense mutations were detected in a compound heterozygous state, including 4 novel mutations. The most severe phenotypes were shared among all affected patients in each family, irrespective of mutation types.Our data suggest a strong genotype-phenotype relationship in ARPKD, with minimal intra-familial heterogeneity. These findings are important for informing future reproductive planning in affected families.

Publication types

  • Observational Study

MeSH terms

  • Aborted Fetus
  • Female
  • Genotype
  • Humans
  • Infant, Newborn
  • Male
  • Mutation
  • Phenotype
  • Polycystic Kidney, Autosomal Recessive / genetics*
  • Polycystic Kidney, Autosomal Recessive / mortality*
  • Polycystic Kidney, Autosomal Recessive / pathology
  • Receptors, Cell Surface / genetics*
  • Republic of Korea
  • Severity of Illness Index

Substances

  • PKHD1 protein, human
  • Receptors, Cell Surface